12 Contrarian Ideas for Next Week's E...

12 Contrarian Ideas for Next Week's Earnings Reports

There are 2 comments on the The Motley Fool story from Apr 14, 2011, titled 12 Contrarian Ideas for Next Week's Earnings Reports. In it, The Motley Fool reports that:

A wise investor once said, "Be greedy where others are fearful" -- an old adage to most, but words to live by for the contrarian.

Join the discussion below, or Read more at The Motley Fool.

Place

Toronto, Canada

#1 Apr 14, 2011
Katherine

New York, NY

#2 Feb 10, 2012
This is similar to the vaginal mesh issues circulating in the mainstream media lately. Putting on too much confidence to an inadequately assessed medical device can either cost you your life or give you benefits. However, unlike money matters, a life can never be brought once wasted or lost. The issue on vaginal mesh is one such issue we need to be involved with since it concerns women’s health. If you want to learn more about the dangers of vaginal mesh and how you may avoid it, read through this: http://www.vaginalmeshlawsuit.com/vaginal-mes...

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Gilead Sciences Discussions

Title Updated Last By Comments
News After Trump rally, equity investors move into h... (Mar '17) Mar '17 Retribution 6
News Federal Judge Orders State Provide Mumia Abu-Ja... (Jan '17) Jan '17 truth hurts 1
News Fight over $1,100 hepatitis C pills awaits next... (Dec '14) Dec '14 reneir880 1
News Gilead Sciences Under Investigation for Over-Ch... (Jul '14) Jul '14 Chris 1
News FDA Panel OKs Truvada for HIV Prevention (May '12) May '14 Sheldon 6
News $1,000 hepatitis C pill a tough miracle to swallow (May '14) May '14 Hep C Veterans 1
News Divide over HIV prevention drug Truvada persists (Apr '14) Apr '14 juls 2